TLR9 activation suppresses inflammation in response to Helicobacter pylori infection
Helicobacter pylori ( H. pylori) induces chronic gastritis in humans, and infection can persist for decades. One H. pylori strain-specific constituent that augments disease risk is the cag pathogenicity island. The cag island encodes a type IV secretion system (T4SS) that translocates DNA into host cells. Toll-like receptor 9 (TLR9) is an innate immune receptor that detects hypo-methylated CpG DNA motifs. In this study, we sought to define the role of the H. pylori cag T4SS on TLR9-mediated responses in vivo. H. pylori strain PMSS1 or its cagE − mutant, which fails to assemble a T4SS, were used to infect wild-type or Tlr9 −/− C57BL/6 mice. PMSS1-infected Tlr9 −/− mice developed significantly higher levels of inflammation, despite similar levels of colonization density, compared with PMSS1-infected wild-type mice. These changes were cag dependent, as both mouse genotypes infected with the cagE − mutant only developed minimal inflammation. Tlr9 −/− genotypes did not alter the microbial phenotypes of in vivo-adapted H. pylori strains; therefore, we examined host immunological responses. There were no differences in levels of TH1 or TH2 cytokines in infected mice when stratified by host genotype. However, gastric mucosal levels of IL-17 were significantly increased in infected Tlr9 −/− mice compared with infected wild-type mice, and H. pylori infection of IL-17A −/− mice concordantly led to significantly decreased levels of gastritis. Thus loss of Tlr9 selectively augments the intensity of IL-17-driven immune responses to H. pylori in a cag T4SS-dependent manner. These results suggest that H. pylori utilizes the cag T4SS to manipulate the intensity of the host immune response.
Топ-30
Журналы
|
1
2
3
4
5
|
|
|
Cellular and Molecular Gastroenterology and Hepatology
5 публикаций, 12.82%
|
|
|
Gut Microbes
3 публикации, 7.69%
|
|
|
International Journal of Molecular Sciences
2 публикации, 5.13%
|
|
|
Mediators of Inflammation
2 публикации, 5.13%
|
|
|
bioRxiv
2 публикации, 5.13%
|
|
|
Experimental and Therapeutic Medicine
1 публикация, 2.56%
|
|
|
Diseases
1 публикация, 2.56%
|
|
|
Frontiers in Microbiology
1 публикация, 2.56%
|
|
|
Frontiers in Cellular and Infection Microbiology
1 публикация, 2.56%
|
|
|
Current Microbiology
1 публикация, 2.56%
|
|
|
Trends in Microbiology
1 публикация, 2.56%
|
|
|
Frontiers in Cardiovascular Medicine
1 публикация, 2.56%
|
|
|
Kidney International
1 публикация, 2.56%
|
|
|
Helicobacter
1 публикация, 2.56%
|
|
|
Immunological Medicine
1 публикация, 2.56%
|
|
|
Journal of Infectious Diseases
1 публикация, 2.56%
|
|
|
mBio
1 публикация, 2.56%
|
|
|
Journal of Immunology Research
1 публикация, 2.56%
|
|
|
Infection and Immunity
1 публикация, 2.56%
|
|
|
Aquaculture
1 публикация, 2.56%
|
|
|
International Journal of Oncology
1 публикация, 2.56%
|
|
|
Microbiology spectrum
1 публикация, 2.56%
|
|
|
Future Microbiology
1 публикация, 2.56%
|
|
|
Cell Communication and Signaling
1 публикация, 2.56%
|
|
|
Virulence
1 публикация, 2.56%
|
|
|
Vaccines
1 публикация, 2.56%
|
|
|
Annals of Saudi Medicine
1 публикация, 2.56%
|
|
|
1
2
3
4
5
|
Издатели
|
2
4
6
8
10
|
|
|
Elsevier
10 публикаций, 25.64%
|
|
|
Taylor & Francis
6 публикаций, 15.38%
|
|
|
MDPI
4 публикации, 10.26%
|
|
|
Frontiers Media S.A.
3 публикации, 7.69%
|
|
|
American Society for Microbiology
3 публикации, 7.69%
|
|
|
Hindawi Limited
3 публикации, 7.69%
|
|
|
Cold Spring Harbor Laboratory
3 публикации, 7.69%
|
|
|
Spandidos Publications
2 публикации, 5.13%
|
|
|
Springer Nature
2 публикации, 5.13%
|
|
|
Wiley
1 публикация, 2.56%
|
|
|
Oxford University Press
1 публикация, 2.56%
|
|
|
King Faisal Specialist Hospital and Research Centre
1 публикация, 2.56%
|
|
|
2
4
6
8
10
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.